A carregar...
Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?
BACKGROUND: Ranolazine is a novel antianginal agent that has also been shown to have electrophysiological properties in laboratory models. This is the first clinical evaluation of the antiarrythmic effects of ranolazine. OBJECTIVE: To compare the incidence of cardiac arrhythmias in patients with non...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2548402/ https://ncbi.nlm.nih.gov/pubmed/18332892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncpcardio1153 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|